AnaptysBio Earnings
NASDAQ: ANABHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
AnaptysBio earnings summary
In its most recent report on Nov 12, 2026 (Sep/2026), ANAB posted EPS of $0.11 versus the $0.41 consensus estimate, a negative surprise of 73.2%. AnaptysBio beat the consensus EPS estimate in 2 of the last 3 quarters, with a median surprise of +26.8%. Quarterly EPS is down 93.4% from the same quarter a year earlier.
Across the last 16 reports, ANAB shares moved an average of 6.3% (in either direction) in the first trading session after results, rising 7 times and falling 9 times.
Summary generated from market data by MetaCap's automated system. Methodology
ANAB earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Nov 12, 2026 | $0.41 | $0.11 | -73.2% | +0.8% |
| Nov 10, 2026 | $0.41 | $0.52 | +26.8% | +0.8% |
| Nov 3, 2026 | $0.41 | $0.52 | +26.8% | -0.4% |
| May 12, 2026 | — | $-1.84 | — | -5.4% |
| Mar 3, 2026 | — | $1.66 | — | +17.0% |
| Nov 4, 2025 | — | $0.52 | — | -14.7% |
| Aug 6, 2025 | — | $-1.34 | — | -4.2% |
| May 5, 2025 | — | $-1.28 | — | +3.2% |
| Feb 27, 2025 | — | $-0.43 | — | -2.9% |
| Nov 5, 2024 | — | $-1.14 | — | -10.8% |
| Aug 5, 2024 | — | $-1.71 | — | +2.9% |
| May 9, 2024 | — | $-1.64 | — | +7.1% |
| Mar 11, 2024 | — | $-1.59 | — | -7.6% |
| Nov 2, 2023 | — | $-1.41 | — | -18.4% |
| Aug 7, 2023 | — | $-1.50 | — | +3.2% |
| May 11, 2023 | — | $-1.58 | — | -1.6% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.